A similar but not significant observation was obtained for patients with HER2-positive tumours (adjusted hazard ratio 3.3, 95% CI 0.70–15.30, Supplementary Table S4A) and in TNBC patients (multivariate analysis was not feasible due to small TNBC sample size). Here, ERBB2 is linked to neoplasm.